Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8ZSO

Respirasome close state 2 in presence of metformin (SC-MetC2)

これはPDB形式変換不可エントリーです。
8ZSO の概要
エントリーDOI10.2210/pdb8zso/pdb
EMDBエントリー60422
分子名称NADH-ubiquinone oxidoreductase chain 4L, Cytochrome c oxidase subunit 8, NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1, ... (86 entities in total)
機能のキーワードmetformin, electron transport chain, respirasome, mammalia, membrane protein
由来する生物種Sus scrofa (pig)
詳細
タンパク質・核酸の鎖数79
化学式量合計1679812.28
構造登録者
Teng, F.,He, Z.X.,Hu, Y.Q.,Xu, C.Y.,Guo, R.Y.,Zhou, L. (登録日: 2024-06-05, 公開日: 2025-11-19, 最終更新日: 2026-02-04)
主引用文献He, Z.,Teng, F.,Yang, Y.,Guo, R.,Wu, M.,Han, F.,Tian, H.,Wang, J.,Hu, Y.,Jiang, Y.,Zhang, L.,Xu, C.,Yang, F.,Zhou, J.,Zhang, S.,Letts, J.A.,Zhou, R.,Zhou, L.
Hydrophilic metformin and hydrophobic biguanides inhibit mitochondrial complex I by distinct mechanisms.
Nat.Struct.Mol.Biol., 33:100-111, 2026
Cited by
PubMed Abstract: Metformin is the only antihyperglycemic biguanide targeting type 2 diabetes mellitus with proven safety. Although a mechanism of action involving tight inhibition of the respiratory complex I has been proposed for hydrophobic biguanides, it remains elusive for the hydrophilic metformin, whose excellent pharmacological tolerance depends on weak complex I inhibition without competitive nature. Here we solved cryo-electron microscopy structures of the metformin-bound porcine respirasome. Our structural and kinetic data are consistent with a model in which metformin enters complex I only in its open state and becomes trapped at the ubiquinone redox site by ubiquinone-induced conformational closing of the enzyme. By contrast, the hydrophobic proguanil alone occupies both the entrance and the redox site of the ubiquinone channel in open and closed complex I and is kinetically consistent with competitive inhibition with conformation-dependent affinities. Our data provide the molecular basis for metformin's well-known superior properties, such as a wide therapeutic window and positive ubiquinone cooperativity, leading to its clinical success and facilitating future therapeutic developments.
PubMed: 41214295
DOI: 10.1038/s41594-025-01710-6
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (3.11 Å)
構造検証レポート
Validation report summary of 8zso
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon